ingenol mebutate derivatives (LEO Pharma)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameingenol mebutate derivatives (LEO Pharma)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsKeratosisSkin Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesLeo Pharma A/S

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesLeo Pharma A/S

Active IndicationsN/A

Inactive IndicationsKeratosisSkin Neoplasms

ATC CodeN/A